Skip to content
Catalyst

metforminPapers

Papers about metformin

papers
3,982
41 years, by papers

Newest first

201 to 250 of 3,982

Every paper here, unless its row says otherwiseIndexed under metformin in PubMed; returned by a PubMed search for metformin

  • A 52-Week Efficacy and Safety Study of Teneligliptin, as an Add-On to Empagliflozin and Metformin in Patients With Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial (TERA305 Study).

    Diabetes, obesity & metabolism2026PMID 42832816

  • Early insulin combined with metformin therapy and long-term risks of cardiovascular disease, kidney disease, and cancer in newly diagnosed type 2 diabetes: a real-world cohort study in China.

    Frontiers in endocrinology2026PMID 42835393

  • Harnessing the Therapeutic Potential of Locally Delivered 1% Metformin Gel for Modulation of Clinical and Inflammatory Parameters in Peri-Implantitis Disease: A Prospective Clinical Evaluation.

    Journal of long-term effects of medical implants2026PMID 42870643

  • Biomarker Modulation by Aspirin and Metformin for Colorectal Cancer Prevention: Results from the ASAMET Randomized Phase II Trial.

    Cancer research communications2026PMID 42895896

  • Preeclampsia Risk in Obese Pregnant Women without Diabetes Mellitus: a Meta-Analysis Comparing Metformin versus Control Group.

    Revista brasileira de ginecologia e obstetricia2026PMID 42924392

  • Early Metformin Initiation and Glycemic Outcomes in Gestational Diabetes: A Secondary Analysis of a Randomized Clinical Trial.

    JAMA network open2026PMID 42975901

  • Targeting Accelerated Aging in COPD: The AMICO (A Trial of Metformin In COpd) Trial Design.

    COPD2026PMID 42980248

  • Effects of Lactobacillus crispatus-Containing Probiotics and Metformin on Insulin Resistance, Inflammation, and Gut Microbiome in Polycystic Ovary Syndrome: Protocol for an Open-Label Randomized Controlled Trial.

    JMIR research protocols2026PMID 42987300

  • Dipeptidyl Peptidase 4 Inhibitors vs Metformin for New-onset Dementia: A Propensity Score-matched Cohort Study.

    The Journal of clinical endocrinology and metabolism2025PMID 38652239

  • Effects of Liraglutide on Leptin Promoter Methylation in Ovarian Granulosa Cells of Patients with Polycystic Ovary Syndrome and Obesity.

    Gynecologic and obstetric investigation2025PMID 38768579Indexed under metformin in PubMed's chemical list

  • Effect of metformin on hepatocellular carcinoma patients with type II diabetes receiving transarterial chemoembolization: a multicenter retrospective cohort study.

    International journal of surgery (London, England)2025PMID 38935094

  • Renal Protective Effect of Metformin in Type 2 Diabetes Patients.

    The Journal of clinical endocrinology and metabolism2025PMID 38986038

  • Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study.

    Inflammatory bowel diseases2025PMID 39001616

  • Effect of metformin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from real-world studies.

    Prostate cancer and prostatic diseases2025PMID 39014063

  • Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes.

    Ophthalmology2025PMID 39182626

  • The impact of metformin on mortality in patients with type 2 diabetes mellitus: a prospective cohort study.

    Endocrine2025PMID 39190051

  • Topiramate Added to Metformin for Obesity Control in Women With Polycystic Ovary Syndrome.

    The Journal of clinical endocrinology and metabolism2025PMID 39271474

  • Clinical outcomes in type 2 diabetes patients with chronic heart failure treated with metformin: a meta-analysis.

    Endocrine2025PMID 39277567

  • Metformin Improves the Function of Abdominal Aortic Aneurysm Patient-Derived Aortic Smooth Muscle Cells.

    European journal of vascular and endovascular surgery2025PMID 39321955

  • Comparison of metformin with inositol versus metformin alone in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.

    Endocrine2025PMID 39331347

  • Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.

    Progress in neuro-psychopharmacology & biological psychiatry2025PMID 39357666

  • Effects of testosterone and metformin on the GlycanAge index of biological age and the composition of the IgG glycome.

    GeroScience2025PMID 39363095

  • Subclinical Hyperthyroidism Enhances Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women.

    Journal of clinical pharmacology2025PMID 39363530

  • Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, parallel-group, placebo-controlled phase III study.

    Diabetes, obesity & metabolism2025PMID 39375869Indexed under metformin in PubMed

  • Effects of acarbose and metformin on thyroid function and thyroid hormone sensitivity in type 2 diabetes patients: a post-hoc analysis of the MARCH study.

    Journal of endocrinological investigation2025PMID 39400888

  • Urgent-Start Peritoneal Dialysis in Metformin-Associated Lactic Acidosis: A Critical Alternative when Immediate Hemodialysis Is Unavailable.

    Blood purification2025PMID 39401490

  • The Effects of Metformin on Cisplatin-Induced Ototoxicity in Diabetic Patients.

    Otolaryngology--head and neck surgery2025PMID 39460639

  • High Frequency of Defecation under Metformin Use May Be a Potential Glucose-lowering Factor Independent of the Dose-dependent Effect of Metformin in Patients with Type 2 Diabetes Mellitus.

    Internal medicine (Tokyo, Japan)2025PMID 39462598

  • The Optimal Dosage and Duration of Metformin for Prevention and Treatment of Antipsychotic-Induced Weight Gain: An Updated Systematic Review and Meta-Analysis.

    Schizophrenia bulletin2025PMID 39509416Also tests metformin

  • Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study.

    American journal of kidney diseases2025PMID 39521399

  • Obesity-specific improvement of lung cancer outcomes and immunotherapy efficacy with metformin.

    Journal of the National Cancer Institute2025PMID 39560490

  • Differential effects of imeglimin and metformin on insulin and incretin secretion-An exploratory randomized controlled trial.

    Diabetes, obesity & metabolism2025PMID 39592886

  • Effect of dapagliflozin on renal haemodynamics in hyperfiltering T2D patients.

    Diabetes, obesity & metabolism2025PMID 39604709Indexed under metformin in PubMed's chemical list

  • Efficacy of Dapagliflozin + Sitagliptin + Metformin Versus Sitagliptin + Metformin in T2DM Inadequately Controlled on Metformin Monotherapy: A Multicentric Randomized Trial.

    Advances in therapy2025PMID 39636567

  • Metformin Treatment With or Without Mediterranean Diet for the Prevention of Age-Related Diseases in People With Metabolic Syndrome: The MeMeMe Randomized Trial.

    Diabetes care2025PMID 39641916

  • Upstream targeting for the prevention of atrial fibrillation: Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)-rationale and study design.

    Journal of interventional cardiac electrophysiology2025PMID 39671157

  • Real-world safety of dapagliflozin plus metformin in patients of type 2 diabetes mellitus in China: Post-hoc analysis of the DONATE study.

    Diabetes research and clinical practice2025PMID 39675486

  • Metformin efficacy and safety as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled trial.

    Journal of psychopharmacology (Oxford, England)2025PMID 39676223

  • Metformin and risk of adverse pregnancy outcomes among pregnant women with gestational diabetes in the United Kingdom: A population-based cohort study.

    Diabetes, obesity & metabolism2025PMID 39676749

  • Metformin lowers risk of hearing loss and mortality in type 2 diabetes.

    Diabetes, obesity & metabolism2025PMID 39690329

  • The effect of semaglutide combined with metformin on liver inflammation and pancreatic beta-cell function in patients with type 2 diabetes and non-alcoholic fatty liver disease.

    Journal of diabetes and its complications2025PMID 39700591

  • Dapagliflozin reduces the white coat effect on systolic blood pressure of patients with type 2 diabetes: a post-hoc analysis from the ADDENDA-BHS 2 trial.

    Current medical research and opinion2025PMID 39706688Indexed under metformin in PubMed's chemical list

  • Positive impact of DPP-4 or SGLT2 inhibitors on mild cognitive impairment in type 2 diabetes patients on metformin therapy: A metabolomic mechanistic insight.

    Biomedicine & pharmacotherapy2025PMID 39709941

  • Gastrointestinal symptoms in patients receiving imeglimin in combination with metformin: A post-hoc analysis of imeglimin clinical trial data.

    Journal of diabetes investigation2025PMID 39723797

  • Efficacy of imeglimin treatment versus metformin dose escalation on glycemic control in subjects with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: A multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study).

    Diabetes, obesity & metabolism2025PMID 39726204

  • Repurposing of Metformin to Improve Survival Outcomes in Patients With Upper Tract Urothelial Carcinoma.

    Cancer medicine2025PMID 39757744

  • Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover Study.

    Diabetes2025PMID 39761379

  • Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis.

    Diabetes, obesity & metabolism2025PMID 39762971Indexed under metformin in PubMed's chemical list

  • Comparative efficacy of GLP-1 RAs/SGLT-2 inhibitors in reducing cardiovascular events in type 2 diabetes according to baseline use of metformin: a systematic review and meta-analysis of randomized controlled trials.

    European journal of medical research2025PMID 39773332

  • Association of metformin use with risk and survival outcome of esophageal cancer in patients with diabetes: A systematic review and meta-analysis.

    PloS one2025PMID 39774829

The next 50 papers

← Previous 50